Zileuton Tablet, Film Coated, Extended Release
Product Images NDC 72603-246

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zileuton (NDC 72603-246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zileuton-container-label (Zileuton Container Label)

Zileuton-container-label (Zileuton Container Label)
This text provides information about NDC 72603-246-01, Zileuton Extended-Release Tablets. Each film-coated tablet contains 600 mg of zieuton USP. The recommended dosage is 2 tablets BID. It is advised not to chew, cut, or crush the tablets. Storage instructions include keeping the tablets at 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F), and protecting them from light. The tablets should be dispensed in a light-resistant container, and the seal should not be accepted if broken or missing. It is manufactured for Northstar Rx LLC in Memphis, TN, and by Amora Pharma Pvt. Ltd. in India. Additional details regarding batch coding and manufacturing information are provided in the text.*
FDA Label Image

Zileutonertabfigure (Zileutonertabfigure)

Zileutonertabfigure (Zileutonertabfigure)
This dataset shows the results of a study involving Zileuton Extended-Release Tablets compared to a placebo over multiple weeks. The number of participants in each group is provided along with the corresponding data collected at weeks 0, 2, 4, 8, 12, and at the endpoint.*
FDA Label Image

Zileutonertabstructure (Zileutonertabstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.